DARZALEX® Daratumumab Injection User Manual

User manual for DARZALEX® (daratumumab injection) for treating multiple myeloma in adults.


DARZALEX® Daratumumab Injection User Manual - cover page
Brand
DARZALEX®
Category
Health Care
Document type
User Manual
Language
Chinese
Pages
37
File format
PDF
File size
2.6 MB
Published
06 November, 2026
Updated
06 November, 2026
MD5 checksum
164CE221B6072349A552A76C18088573

About this manual

This document is the user manual for DARZALEX® (daratumumab injection), a medication used to treat multiple myeloma in adults. It provides detailed instructions for administration, dosage, and management of infusion-related reactions. The drug is administered intravenously and must be diluted with 0.9% sodium chloride injection. Dosage varies based on treatment regimen (e.g., with lenalidomide and dexamethasone or with bortezomib, melphalan, and prednisone). This manual is written in Chinese.

What's inside

  • 药品名称
  • 成份
  • 性状
  • 适应症
  • 规格
  • 用法用量
  • 不良反应
  • 输注相关反应的管理
  • 特殊人群
  • 给药方法

Specifications

推荐剂量16 mg/kg

Frequently asked questions

如何稀释达雷妥尤单抗注射液?

应使用 9mg/mL(0.9%)氯化钠注射液稀释后静脉内输注。

达雷妥尤单抗注射液适用于哪些患者?

适用于不适合自体干细胞移植的新诊断多发性骨髓瘤成年患者,既往至少接受过一线治疗的多发性骨髓瘤成年患者,以及复发和难治性多发性骨髓瘤成年患者。

Download PDF (2.6 MB)